Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroprotective Effect of Fisetin Against Amyloid-Beta-Induced Cognitive/Synaptic Dysfunction, Neuroinflammation, and Neurodegeneration in Adult Mice
Ashfaq Ahmad, Tahir Ali, Hyun‐Young Park, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 3, pp. 2269-2285
Closed Access | Times Cited: 186

Showing 1-25 of 186 citing articles:

Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s Disease
Tahir Ali, Tae Hyun Kim, Shafiq Ur Rehman, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 7, pp. 6076-6093
Closed Access | Times Cited: 405
Neuroprotective Effect of Quercetin Against the Detrimental Effects of LPS in the Adult Mouse Brain
Amjad Khan, Tahir Ali, Shafiq Ur Rehman, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 212
Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies
Stéphanie Andrade, Maria João Ramalho, Joana A. Loureiro, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2313-2313
Open Access | Times Cited: 201
The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases
Pamela Maher
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 3056-3056
Open Access | Times Cited: 196
Flavonoids as Therapeutic Agents in Alzheimer’s and Parkinson’s Diseases: A Systematic Review of Preclinical Evidences
Roxana Braga de Andrade Teles, Tâmara Coimbra Diniz, Tiago Coimbra Costa Pinto, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 176
Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer’s Disease
Manish Kumar, Nitin Bansal
Molecular Neurobiology (2021) Vol. 59, Iss. 1, pp. 354-385
Closed Access | Times Cited: 122
The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress
Syed Shams ul Hassan, Saptadip Samanta, Raju Dash, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 76
Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer’s disease
Hind Muteb Albadrani, Payal Chauhan, Sumel Ashique, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116376-116376
Open Access | Times Cited: 15
Inhibition of protein misfolding and aggregation by natural phenolic compounds
Zohra Dhouafli, Karina Cuanalo-Contreras, El Akrem Hayouni, et al.
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 19, pp. 3521-3538
Open Access | Times Cited: 141
FGF21 Attenuates High-Fat Diet-Induced Cognitive Impairment via Metabolic Regulation and Anti-inflammation of Obese Mice
Qingzhi Wang, Jing Yuan, Zhanyang Yu, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 6, pp. 4702-4717
Open Access | Times Cited: 140
Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against Aβ1-42-induced neuroinflammation and neurodegeneration via the NF-KB /JNK/GSK3β signaling pathway
Min Ju Kim, Shafiq Ur Rehman, Faiz Ul Amin, et al.
Nanomedicine Nanotechnology Biology and Medicine (2017) Vol. 13, Iss. 8, pp. 2533-2544
Closed Access | Times Cited: 138
Anthocyanin-Loaded PEG-Gold Nanoparticles Enhanced the Neuroprotection of Anthocyanins in an Aβ1–42 Mouse Model of Alzheimer’s Disease
Tahir Ali, Min Ju Kim, Shafiq Ur Rehman, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 8, pp. 6490-6506
Closed Access | Times Cited: 111
Anthocyanins Improve Hippocampus-Dependent Memory Function and Prevent Neurodegeneration via JNK/Akt/GSK3β Signaling in LPS-Treated Adult Mice
Muhammad Sohail Khan, Tahir Ali, Min Woo Kim, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 1, pp. 671-687
Closed Access | Times Cited: 111
Anthocyanins protect against LPS-induced oxidative stress-mediated neuroinflammation and neurodegeneration in the adult mouse cortex
Muhammad Sohail Khan, Tahir Ali, Min Woo Kim, et al.
Neurochemistry International (2016) Vol. 100, pp. 1-10
Closed Access | Times Cited: 108
A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease
Leili Jalili‐Baleh, Elaheh Babaei, Shahin Abdpour, et al.
European Journal of Medicinal Chemistry (2018) Vol. 152, pp. 570-589
Closed Access | Times Cited: 104
Natural products attenuate PI3K/Akt/mTOR signaling pathway: A promising strategy in regulating neurodegeneration
Sajad Fakhri, Amin Iranpanah, Mohammad Mehdi Gravandi, et al.
Phytomedicine (2021) Vol. 91, pp. 153664-153664
Closed Access | Times Cited: 89
Fisetin improves lead-induced neuroinflammation, apoptosis and synaptic dysfunction in mice associated with the AMPK/SIRT1 and autophagy pathway
Wei Yang, Zhi-Kai Tian, Huixin Yang, et al.
Food and Chemical Toxicology (2019) Vol. 134, pp. 110824-110824
Closed Access | Times Cited: 82
Fisetin, potential flavonoid with multifarious targets for treating neurological disorders: An updated review
Arun Reddy Ravula, Suraj B. Teegala, Kalakotla Shanker, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174492-174492
Closed Access | Times Cited: 79
Role of Endogenous Lipopolysaccharides in Neurological Disorders
Manjunath Kalyan, A. H. Tousif, Sharma Sonali, et al.
Cells (2022) Vol. 11, Iss. 24, pp. 4038-4038
Open Access | Times Cited: 68
Therapeutic benefits of flavonoids against neuroinflammation: a systematic review
Hamsalakshmi, Ann Maria Alex, Mahalakshmi Arehally Marappa, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 1, pp. 111-136
Closed Access | Times Cited: 48
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 975-975
Open Access | Times Cited: 45
Protective Effects of Flavonoids against Alzheimer’s Disease: Pathological Hypothesis, Potential Targets, and Structure–Activity Relationship
Jiao Li, Min Sun, Xiaodong Cui, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10020-10020
Open Access | Times Cited: 40
The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer’s disease: a narrative review
Qian Zhang, Yaping Yan
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2582-2591
Open Access | Times Cited: 29
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Adelaide Carrara, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 180-180
Open Access | Times Cited: 24
Fisetin—In Search of Better Bioavailability—From Macro to Nano Modifications: A Review
Joanna Szymczak, Judyta Cielecka‐Piontek
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14158-14158
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top